ArticleNature communications2018

Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma.

Sébastien Corre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.